CA2706729A1 - Gene expression markers for inflammatory bowel disease - Google Patents

Info

Publication number

CA2706729A1

CA2706729A1 CA2706729A CA2706729A CA2706729A1 CA 2706729 A1 CA2706729 A1 CA 2706729A1 CA 2706729 A CA2706729 A CA 2706729A CA 2706729 A CA2706729 A CA 2706729A CA 2706729 A1 CA2706729 A1 CA 2706729A1

Authority

CA

Canada

Prior art keywords

ibd

expression

seq

acid sequence

polypeptide

Prior art date

2007-11-29

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 208000022559 Inflammatory bowel disease Diseases 0.000 title claims abstract description 392
• 230000014509 gene expression Effects 0.000 title claims abstract description 350
• 238000000034 method Methods 0.000 claims abstract description 232
• 238000012360 testing method Methods 0.000 claims abstract description 85
• 238000011223 gene expression profiling Methods 0.000 claims abstract description 11
• 206010009900 Colitis ulcerative Diseases 0.000 claims description 316
• 201000006704 Ulcerative Colitis Diseases 0.000 claims description 315
• 108090000623 proteins and genes Proteins 0.000 claims description 301
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 201
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 200
• 229920001184 polypeptide Polymers 0.000 claims description 198
• 238000001574 biopsy Methods 0.000 claims description 194
• 208000011231 Crohn disease Diseases 0.000 claims description 157
• 150000007523 nucleic acids Chemical class 0.000 claims description 149
• 241000282414 Homo sapiens Species 0.000 claims description 124
• 239000003814 drug Substances 0.000 claims description 87
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 67
• 210000001519 tissue Anatomy 0.000 claims description 60
• 210000001599 sigmoid colon Anatomy 0.000 claims description 56
• 238000011282 treatment Methods 0.000 claims description 55
• 229940124597 therapeutic agent Drugs 0.000 claims description 42
• 102000039446 nucleic acids Human genes 0.000 claims description 30
• 108020004707 nucleic acids Proteins 0.000 claims description 30
• 210000003405 ileum Anatomy 0.000 claims description 23
• 238000001356 surgical procedure Methods 0.000 claims description 20
• 238000001514 detection method Methods 0.000 claims description 15
• 230000000112 colonic effect Effects 0.000 claims description 14
• WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical group NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 claims description 13
• 229940113720 aminosalicylate Drugs 0.000 claims description 13
• 239000003246 corticosteroid Substances 0.000 claims description 12
• 230000002757 inflammatory effect Effects 0.000 claims description 12
• 210000001731 descending colon Anatomy 0.000 claims description 11
• 210000001815 ascending colon Anatomy 0.000 claims description 9
• 210000004953 colonic tissue Anatomy 0.000 claims description 9
• 208000035475 disorder Diseases 0.000 claims description 8
• 229940125721 immunosuppressive agent Drugs 0.000 claims description 8
• 239000003018 immunosuppressive agent Substances 0.000 claims description 7
• 230000008506 pathogenesis Effects 0.000 abstract description 10
• 125000003275 alpha amino acid group Chemical group 0.000 description 145
• 239000000523 sample Substances 0.000 description 141
• 108091028043 Nucleic acid sequence Proteins 0.000 description 120
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 87
• 210000004027 cell Anatomy 0.000 description 57
• 201000010099 disease Diseases 0.000 description 57
• 102000004169 proteins and genes Human genes 0.000 description 53
• 238000003752 polymerase chain reaction Methods 0.000 description 52
• 239000003550 marker Substances 0.000 description 50
• 239000013615 primer Substances 0.000 description 49
• 206010061218 Inflammation Diseases 0.000 description 47
• 230000004054 inflammatory process Effects 0.000 description 47
• 235000018102 proteins Nutrition 0.000 description 47
• 238000004458 analytical method Methods 0.000 description 44
• 210000001072 colon Anatomy 0.000 description 43
• 239000000427 antigen Substances 0.000 description 42
• 230000027455 binding Effects 0.000 description 42
• 230000001684 chronic effect Effects 0.000 description 42
• 108020004414 DNA Proteins 0.000 description 41
• 108091007433 antigens Proteins 0.000 description 40
• 102000036639 antigens Human genes 0.000 description 40
• 239000000047 product Substances 0.000 description 37
• 230000001105 regulatory effect Effects 0.000 description 37
• 238000002493 microarray Methods 0.000 description 32
• 230000000694 effects Effects 0.000 description 31
• 239000012634 fragment Substances 0.000 description 30
• 238000003556 assay Methods 0.000 description 29
• 230000008859 change Effects 0.000 description 27
• 102100029790 Defensin-6 Human genes 0.000 description 24
• 101000990915 Homo sapiens Stromelysin-1 Proteins 0.000 description 24
• 101000685275 Homo sapiens Protein sel-1 homolog 1 Proteins 0.000 description 23
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 23
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 23
• 102100023159 Protein sel-1 homolog 1 Human genes 0.000 description 23
• 238000009396 hybridization Methods 0.000 description 23
• 210000000664 rectum Anatomy 0.000 description 22
• 102100021420 Defensin-5 Human genes 0.000 description 21
• 102100030416 Stromelysin-1 Human genes 0.000 description 21
• 238000013461 design Methods 0.000 description 21
• 108020004999 messenger RNA Proteins 0.000 description 21
• 238000006467 substitution reaction Methods 0.000 description 21
• 101710178511 Defensin-6 Proteins 0.000 description 20
• 101000990912 Homo sapiens Matrilysin Proteins 0.000 description 20
• 108060003951 Immunoglobulin Proteins 0.000 description 20
• 102000018358 immunoglobulin Human genes 0.000 description 20
• 208000001234 inflammatory bowel disease 5 Diseases 0.000 description 20
• 239000003795 chemical substances by application Substances 0.000 description 19
• 238000003745 diagnosis Methods 0.000 description 19
• 230000001965 increasing effect Effects 0.000 description 19
• 102000040430 polynucleotide Human genes 0.000 description 19
• 108091033319 polynucleotide Proteins 0.000 description 19
• 102100030417 Matrilysin Human genes 0.000 description 18
• 210000001035 gastrointestinal tract Anatomy 0.000 description 18
• 239000002157 polynucleotide Substances 0.000 description 18
• 101710178517 Defensin-5 Proteins 0.000 description 17
• 230000001154 acute effect Effects 0.000 description 17
• 230000000875 corresponding effect Effects 0.000 description 17
• 238000005516 engineering process Methods 0.000 description 17
• 235000001014 amino acid Nutrition 0.000 description 16
• 238000013459 approach Methods 0.000 description 16
• 210000000349 chromosome Anatomy 0.000 description 16
• 102000004190 Enzymes Human genes 0.000 description 15
• 108090000790 Enzymes Proteins 0.000 description 15
• 229940088598 enzyme Drugs 0.000 description 15
• 210000003134 paneth cell Anatomy 0.000 description 15
• 239000002987 primer (paints) Substances 0.000 description 15
• 238000002560 therapeutic procedure Methods 0.000 description 15
• 230000006022 acute inflammation Effects 0.000 description 14
• 208000038016 acute inflammation Diseases 0.000 description 14
• 238000006243 chemical reaction Methods 0.000 description 14
• 238000010208 microarray analysis Methods 0.000 description 14
• 238000003757 reverse transcription PCR Methods 0.000 description 14
• 108090001007 Interleukin-8 Proteins 0.000 description 13
• 102000004890 Interleukin-8 Human genes 0.000 description 13
• 241001465754 Metazoa Species 0.000 description 13
• 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 13
• 239000002299 complementary DNA Substances 0.000 description 13
• 238000011161 development Methods 0.000 description 13
• 230000018109 developmental process Effects 0.000 description 13
• 108010001267 Protein Subunits Proteins 0.000 description 12
• 108010016200 Zinc Finger Protein GLI1 Proteins 0.000 description 12
• 102000018568 alpha-Defensin Human genes 0.000 description 12
• 108050007802 alpha-defensin Proteins 0.000 description 12
• 150000001413 amino acids Chemical class 0.000 description 12
• 238000007901 in situ hybridization Methods 0.000 description 12
• 230000000968 intestinal effect Effects 0.000 description 12
• 238000004519 manufacturing process Methods 0.000 description 12
• 238000003753 real-time PCR Methods 0.000 description 12
• 238000010186 staining Methods 0.000 description 12
• 229940024606 amino acid Drugs 0.000 description 11
• 230000001413 cellular effect Effects 0.000 description 11
• 239000003153 chemical reaction reagent Substances 0.000 description 11
• 238000000338 in vitro Methods 0.000 description 11
• 230000011987 methylation Effects 0.000 description 11
• 238000007069 methylation reaction Methods 0.000 description 11
• 239000000203 mixture Substances 0.000 description 11
• 230000037361 pathway Effects 0.000 description 11
• 230000004044 response Effects 0.000 description 11
• 241000894007 species Species 0.000 description 11
• 239000000758 substrate Substances 0.000 description 11
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 10
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
• 102100035535 Zinc finger protein GLI1 Human genes 0.000 description 10
• 230000003321 amplification Effects 0.000 description 10
• 206010009887 colitis Diseases 0.000 description 10
• 238000003364 immunohistochemistry Methods 0.000 description 10
• 238000003199 nucleic acid amplification method Methods 0.000 description 10
• 230000002829 reductive effect Effects 0.000 description 10
• 101001096072 Homo sapiens Regenerating islet-derived protein 3-gamma Proteins 0.000 description 9
• 241000699670 Mus sp. Species 0.000 description 9
• 108091034117 Oligonucleotide Proteins 0.000 description 9
• 238000002123 RNA extraction Methods 0.000 description 9
• 230000004071 biological effect Effects 0.000 description 9
• 208000037976 chronic inflammation Diseases 0.000 description 9
• 238000010195 expression analysis Methods 0.000 description 9
• 210000004408 hybridoma Anatomy 0.000 description 9
• 210000004969 inflammatory cell Anatomy 0.000 description 9
• 230000008569 process Effects 0.000 description 9
• 238000012163 sequencing technique Methods 0.000 description 9
• 210000002966 serum Anatomy 0.000 description 9
• 208000024891 symptom Diseases 0.000 description 9
• 230000001225 therapeutic effect Effects 0.000 description 9
• NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 8
• 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 8
• 102100028308 Immunoglobulin heavy variable 4-4 Human genes 0.000 description 8
• 101710098086 Immunoglobulin heavy variable 4-4 Proteins 0.000 description 8
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 8
• 206010054949 Metaplasia Diseases 0.000 description 8
• 108090000704 Tubulin Proteins 0.000 description 8
• 102000004243 Tubulin Human genes 0.000 description 8
• 125000000539 amino acid group Chemical group 0.000 description 8
• 230000006020 chronic inflammation Effects 0.000 description 8
• 238000002052 colonoscopy Methods 0.000 description 8
• 230000000295 complement effect Effects 0.000 description 8
• 229940079593 drug Drugs 0.000 description 8
• 238000002474 experimental method Methods 0.000 description 8
• 230000015689 metaplastic ossification Effects 0.000 description 8
• 238000000746 purification Methods 0.000 description 8
• 238000010839 reverse transcription Methods 0.000 description 8
• 238000003196 serial analysis of gene expression Methods 0.000 description 8
• 239000000126 substance Substances 0.000 description 8
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 7
• 244000060234 Gmelina philippensis Species 0.000 description 7
• 101000713099 Homo sapiens C-C motif chemokine 20 Proteins 0.000 description 7
• 101000846908 Homo sapiens Fc receptor-like protein 5 Proteins 0.000 description 7
• 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 description 7
• 101001099557 Homo sapiens PDZ domain-containing protein 9 Proteins 0.000 description 7
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 7
• 108010000684 Matrix Metalloproteinases Proteins 0.000 description 7
• 102100038548 PDZ domain-containing protein 9 Human genes 0.000 description 7
• 238000011529 RT qPCR Methods 0.000 description 7
• 108091006736 SLC22A5 Proteins 0.000 description 7
• 102000010821 Solute Carrier Family 22 Member 5 Human genes 0.000 description 7
• 239000012472 biological sample Substances 0.000 description 7
• 238000004891 communication Methods 0.000 description 7
• 239000000975 dye Substances 0.000 description 7
• 230000006870 function Effects 0.000 description 7
• 230000004927 fusion Effects 0.000 description 7
• 102000055297 human CXCL1 Human genes 0.000 description 7
• 230000028993 immune response Effects 0.000 description 7
• 238000003780 insertion Methods 0.000 description 7
• 230000037431 insertion Effects 0.000 description 7
• 208000002551 irritable bowel syndrome Diseases 0.000 description 7
• 238000012775 microarray technology Methods 0.000 description 7
• 230000035772 mutation Effects 0.000 description 7
• 238000010606 normalization Methods 0.000 description 7
• 239000002773 nucleotide Substances 0.000 description 7
• 238000012552 review Methods 0.000 description 7
• 230000003827 upregulation Effects 0.000 description 7
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 6
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 6
• 102000053602 DNA Human genes 0.000 description 6
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
• 101000990902 Homo sapiens Matrix metalloproteinase-9 Proteins 0.000 description 6
• 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 6
• 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 6
• 108091092195 Intron Proteins 0.000 description 6
• 102000002274 Matrix Metalloproteinases Human genes 0.000 description 6
• 206010028980 Neoplasm Diseases 0.000 description 6
• 241000283973 Oryctolagus cuniculus Species 0.000 description 6
• 206010035226 Plasma cell myeloma Diseases 0.000 description 6
• 102000002067 Protein Subunits Human genes 0.000 description 6
• -1 SI0OA8 Proteins 0.000 description 6
• 102100039360 Toll-like receptor 4 Human genes 0.000 description 6
• 230000004075 alteration Effects 0.000 description 6
• 239000000090 biomarker Substances 0.000 description 6
• 239000000872 buffer Substances 0.000 description 6
• 238000004113 cell culture Methods 0.000 description 6
• 239000013068 control sample Substances 0.000 description 6
• 229960001334 corticosteroids Drugs 0.000 description 6
• 230000002068 genetic effect Effects 0.000 description 6
• 210000004602 germ cell Anatomy 0.000 description 6
• 230000012010 growth Effects 0.000 description 6
• 230000001900 immune effect Effects 0.000 description 6
• 208000015181 infectious disease Diseases 0.000 description 6
• XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
• 239000000463 material Substances 0.000 description 6
• 230000001404 mediated effect Effects 0.000 description 6
• GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 6
• 230000004048 modification Effects 0.000 description 6
• 238000012986 modification Methods 0.000 description 6
• 201000000050 myeloid neoplasm Diseases 0.000 description 6
• 150000002482 oligosaccharides Polymers 0.000 description 6
• 230000007170 pathology Effects 0.000 description 6
• 238000002360 preparation method Methods 0.000 description 6
• 230000003252 repetitive effect Effects 0.000 description 6
• 238000002271 resection Methods 0.000 description 6
• 238000000926 separation method Methods 0.000 description 6
• 239000000243 solution Substances 0.000 description 6
• NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 6
• 102100025430 Butyrophilin-like protein 3 Human genes 0.000 description 5
• 108010078791 Carrier Proteins Proteins 0.000 description 5
• 206010009944 Colon cancer Diseases 0.000 description 5
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 5
• 108010036949 Cyclosporine Proteins 0.000 description 5
• 102000004127 Cytokines Human genes 0.000 description 5
• 108090000695 Cytokines Proteins 0.000 description 5
• 102000000541 Defensins Human genes 0.000 description 5
• 108010002069 Defensins Proteins 0.000 description 5
• 102100031780 Endonuclease Human genes 0.000 description 5
• 108700039887 Essential Genes Proteins 0.000 description 5
• 108700024394 Exon Proteins 0.000 description 5
• 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 5
• 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 5
• 101000934741 Homo sapiens Butyrophilin-like protein 3 Proteins 0.000 description 5
• 101000983528 Homo sapiens Caspase-8 Proteins 0.000 description 5
• 101001041589 Homo sapiens Defensin-5 Proteins 0.000 description 5
• 101000865479 Homo sapiens Defensin-6 Proteins 0.000 description 5
• 101000988395 Homo sapiens PDZ and LIM domain protein 4 Proteins 0.000 description 5
• 101000712982 Homo sapiens Ras association domain-containing protein 8 Proteins 0.000 description 5
• 101000636743 Homo sapiens Tumor protein D55 Proteins 0.000 description 5
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 5
• UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 5
• 102100033218 Ras association domain-containing protein 8 Human genes 0.000 description 5
• 102100037886 Regenerating islet-derived protein 3-gamma Human genes 0.000 description 5
• 108091006737 SLC22A4 Proteins 0.000 description 5
• 102100036928 Solute carrier family 22 member 4 Human genes 0.000 description 5
• 101710149775 TNFAIP3-interacting protein 3 Proteins 0.000 description 5
• 102100037666 TNFAIP3-interacting protein 3 Human genes 0.000 description 5
• 102100031913 Tumor protein D55 Human genes 0.000 description 5
• 101001074046 Xenopus laevis Zinc finger protein GLI1 Proteins 0.000 description 5
• LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 5
• 229960002170 azathioprine Drugs 0.000 description 5
• 229960002685 biotin Drugs 0.000 description 5
• 235000020958 biotin Nutrition 0.000 description 5
• 239000011616 biotin Substances 0.000 description 5
• 229960001265 ciclosporin Drugs 0.000 description 5
• 238000012321 colectomy Methods 0.000 description 5
• 229930182912 cyclosporin Natural products 0.000 description 5
• 230000003247 decreasing effect Effects 0.000 description 5
• 238000002405 diagnostic procedure Methods 0.000 description 5
• 230000009274 differential gene expression Effects 0.000 description 5
• 210000000981 epithelium Anatomy 0.000 description 5
• 238000009472 formulation Methods 0.000 description 5
• 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 5
• 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 5
• 230000013595 glycosylation Effects 0.000 description 5
• 238000006206 glycosylation reaction Methods 0.000 description 5
• 239000001963 growth medium Substances 0.000 description 5
• 238000003018 immunoassay Methods 0.000 description 5
• 238000002955 isolation Methods 0.000 description 5
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 5
• 239000011325 microbead Substances 0.000 description 5
• 210000004877 mucosa Anatomy 0.000 description 5
• 125000003729 nucleotide group Chemical group 0.000 description 5
• 230000002441 reversible effect Effects 0.000 description 5
• 230000008410 smoothened signaling pathway Effects 0.000 description 5
• 239000011780 sodium chloride Substances 0.000 description 5
• 239000001509 sodium citrate Substances 0.000 description 5
• 229960001940 sulfasalazine Drugs 0.000 description 5
• NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 5
• 108010058716 transglutaminase 4 Proteins 0.000 description 5
• 238000005406 washing Methods 0.000 description 5
• 102100022464 5'-nucleotidase Human genes 0.000 description 4
• 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 4
• 102100021036 Arrestin domain-containing protein 5 Human genes 0.000 description 4
• 108090001008 Avidin Proteins 0.000 description 4
• 241000894006 Bacteria Species 0.000 description 4
• 108091026890 Coding region Proteins 0.000 description 4
• 238000002965 ELISA Methods 0.000 description 4
• 108010024164 HLA-G Antigens Proteins 0.000 description 4
• WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 4
• 101000784139 Homo sapiens Arrestin domain-containing protein 5 Proteins 0.000 description 4
• 101000895110 Homo sapiens Ataxin-3-like protein Proteins 0.000 description 4
• 101001007225 Homo sapiens BTB/POZ domain-containing protein KCTD8 Proteins 0.000 description 4
• 101000741072 Homo sapiens Caspase-5 Proteins 0.000 description 4
• 101000844721 Homo sapiens Deleted in malignant brain tumors 1 protein Proteins 0.000 description 4
• 101000848629 Homo sapiens E3 ubiquitin-protein ligase TRIM22 Proteins 0.000 description 4
• 101001032113 Homo sapiens Histone deacetylase 7 Proteins 0.000 description 4
• 101000977768 Homo sapiens Interleukin-1 receptor-associated kinase 3 Proteins 0.000 description 4
• 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 description 4
• 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 4
• 101000781950 Homo sapiens Protein Wnt-16 Proteins 0.000 description 4
• 101000637821 Homo sapiens Serum amyloid A-2 protein Proteins 0.000 description 4
• 101000822540 Homo sapiens Sterile alpha motif domain-containing protein 9-like Proteins 0.000 description 4
• 101000845170 Homo sapiens Thymic stromal lymphopoietin Proteins 0.000 description 4
• 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 4
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
• LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 4
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
• 102000001776 Matrix metalloproteinase-9 Human genes 0.000 description 4
• 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 4
• 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 4
• 102000016943 Muramidase Human genes 0.000 description 4
• 108010014251 Muramidase Proteins 0.000 description 4
• 241001529936 Murinae Species 0.000 description 4
• 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 4
• 102100038494 Nuclear receptor subfamily 1 group I member 2 Human genes 0.000 description 4
• 108010001511 Pregnane X Receptor Proteins 0.000 description 4
• 102100032420 Protein S100-A9 Human genes 0.000 description 4
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 4
• 241000283984 Rodentia Species 0.000 description 4
• 108020004459 Small interfering RNA Proteins 0.000 description 4
• 108010006785 Taq Polymerase Proteins 0.000 description 4
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
• 230000002378 acidificating effect Effects 0.000 description 4
• 206010003246 arthritis Diseases 0.000 description 4
• 230000015572 biosynthetic process Effects 0.000 description 4
• 210000004899 c-terminal region Anatomy 0.000 description 4
• 150000001720 carbohydrates Chemical class 0.000 description 4
• 150000001875 compounds Chemical class 0.000 description 4
• 238000004132 cross linking Methods 0.000 description 4
• 238000012217 deletion Methods 0.000 description 4
• 230000037430 deletion Effects 0.000 description 4
• 238000001784 detoxification Methods 0.000 description 4
• 230000003828 downregulation Effects 0.000 description 4
• 238000001861 endoscopic biopsy Methods 0.000 description 4
• 238000001839 endoscopy Methods 0.000 description 4
• 210000002919 epithelial cell Anatomy 0.000 description 4
• 230000002962 histologic effect Effects 0.000 description 4
• 102000044694 human FCRL5 Human genes 0.000 description 4
• 102000052088 human IL3RA Human genes 0.000 description 4
• 102000054439 human MMP9 Human genes 0.000 description 4
• 102000045701 human REG3G Human genes 0.000 description 4
• 210000003917 human chromosome Anatomy 0.000 description 4
• 230000002458 infectious effect Effects 0.000 description 4
• 208000014674 injury Diseases 0.000 description 4
• 238000003046 intermediate neglect of differential overlap Methods 0.000 description 4
• 210000000936 intestine Anatomy 0.000 description 4
• 210000002429 large intestine Anatomy 0.000 description 4
• 230000003902 lesion Effects 0.000 description 4
• 229960000274 lysozyme Drugs 0.000 description 4
• 239000004325 lysozyme Substances 0.000 description 4
• 235000010335 lysozyme Nutrition 0.000 description 4
• 230000007246 mechanism Effects 0.000 description 4
• 239000002609 medium Substances 0.000 description 4
• KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 4
• 238000002703 mutagenesis Methods 0.000 description 4
• 231100000350 mutagenesis Toxicity 0.000 description 4
• 239000013642 negative control Substances 0.000 description 4
• 229960004110 olsalazine Drugs 0.000 description 4
• QQBDLJCYGRGAKP-FOCLMDBBSA-N olsalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=C(C(O)=CC=2)C(O)=O)=C1 QQBDLJCYGRGAKP-FOCLMDBBSA-N 0.000 description 4
• 239000002245 particle Substances 0.000 description 4
• 102000013415 peroxidase activity proteins Human genes 0.000 description 4
• 108040007629 peroxidase activity proteins Proteins 0.000 description 4
• 238000011002 quantification Methods 0.000 description 4
• 238000011160 research Methods 0.000 description 4
• 238000012216 screening Methods 0.000 description 4
• 239000004055 small Interfering RNA Substances 0.000 description 4
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
• 230000002103 transcriptional effect Effects 0.000 description 4
• 239000013598 vector Substances 0.000 description 4
• NBGAYCYFNGPNPV-UHFFFAOYSA-N 2-aminooxybenzoic acid Chemical class NOC1=CC=CC=C1C(O)=O NBGAYCYFNGPNPV-UHFFFAOYSA-N 0.000 description 3
• 108091093088 Amplicon Proteins 0.000 description 3
• 102100021301 Ataxin-3-like protein Human genes 0.000 description 3
• 208000023275 Autoimmune disease Diseases 0.000 description 3
• 102100028232 BTB/POZ domain-containing protein KCTD8 Human genes 0.000 description 3
• 102100036848 C-C motif chemokine 20 Human genes 0.000 description 3
• 102100026548 Caspase-8 Human genes 0.000 description 3
• 102000019034 Chemokines Human genes 0.000 description 3
• 108010012236 Chemokines Proteins 0.000 description 3
• 108010047041 Complementarity Determining Regions Proteins 0.000 description 3
• 108020004635 Complementary DNA Proteins 0.000 description 3
• 108010060374 FSH Receptors Proteins 0.000 description 3
• 102100031507 Fc receptor-like protein 5 Human genes 0.000 description 3
• 206010016717 Fistula Diseases 0.000 description 3
• 102000018343 Follicle stimulating hormone receptors Human genes 0.000 description 3
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
• 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 3
• 101001011896 Homo sapiens Matrix metalloproteinase-19 Proteins 0.000 description 3
• 101001055091 Homo sapiens Mitogen-activated protein kinase kinase kinase 8 Proteins 0.000 description 3
• 101001120760 Homo sapiens Olfactomedin-4 Proteins 0.000 description 3
• 101000842043 Homo sapiens Phenylalanine-tRNA ligase, mitochondrial Proteins 0.000 description 3
• 101001126417 Homo sapiens Platelet-derived growth factor receptor alpha Proteins 0.000 description 3
• 101001135471 Homo sapiens Potassium voltage-gated channel subfamily D member 3 Proteins 0.000 description 3
• 101000601384 Homo sapiens Sialidase-4 Proteins 0.000 description 3
• 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 3
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 3
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 3
• 102000000589 Interleukin-1 Human genes 0.000 description 3
• 108010002352 Interleukin-1 Proteins 0.000 description 3
• 102100023530 Interleukin-1 receptor-associated kinase 3 Human genes 0.000 description 3
• 241000124008 Mammalia Species 0.000 description 3
• 102100030218 Matrix metalloproteinase-19 Human genes 0.000 description 3
• 101710093002 Multiple PDZ domain protein Proteins 0.000 description 3
• 102100021286 Multiple PDZ domain protein Human genes 0.000 description 3
• 241000699666 Mus <mouse, genus> Species 0.000 description 3
• 101710163270 Nuclease Proteins 0.000 description 3
• 102100029178 PDZ and LIM domain protein 4 Human genes 0.000 description 3
• 102100030485 Platelet-derived growth factor receptor alpha Human genes 0.000 description 3
• 239000004365 Protease Substances 0.000 description 3
• 102100036587 Protein Wnt-16 Human genes 0.000 description 3
• 102100038103 Protein-glutamine gamma-glutamyltransferase 4 Human genes 0.000 description 3
• 108020004682 Single-Stranded DNA Proteins 0.000 description 3
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
• ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 3
• 102000056172 Transforming growth factor beta-3 Human genes 0.000 description 3
• 108090000097 Transforming growth factor beta-3 Proteins 0.000 description 3
• 208000025865 Ulcer Diseases 0.000 description 3
• 208000027418 Wounds and injury Diseases 0.000 description 3
• 230000002159 abnormal effect Effects 0.000 description 3
• 230000035508 accumulation Effects 0.000 description 3
• 238000009825 accumulation Methods 0.000 description 3
• 239000002253 acid Substances 0.000 description 3
• 239000002671 adjuvant Substances 0.000 description 3
• 230000003872 anastomosis Effects 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 230000033228 biological regulation Effects 0.000 description 3
• 239000005018 casein Substances 0.000 description 3
• BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
• 235000021240 caseins Nutrition 0.000 description 3
• 239000003593 chromogenic compound Substances 0.000 description 3
• 230000021615 conjugation Effects 0.000 description 3
• 235000018417 cysteine Nutrition 0.000 description 3
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 3
• 230000006378 damage Effects 0.000 description 3
• 230000007423 decrease Effects 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• 239000013604 expression vector Substances 0.000 description 3
• 230000003890 fistula Effects 0.000 description 3
• 239000007850 fluorescent dye Substances 0.000 description 3
• 235000013350 formula milk Nutrition 0.000 description 3
• BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
• 239000003862 glucocorticoid Substances 0.000 description 3
• 230000036541 health Effects 0.000 description 3
• 238000003384 imaging method Methods 0.000 description 3
• 230000002163 immunogen Effects 0.000 description 3
• 230000016784 immunoglobulin production Effects 0.000 description 3
• 238000001114 immunoprecipitation Methods 0.000 description 3
• 230000008676 import Effects 0.000 description 3
• 230000006872 improvement Effects 0.000 description 3
• 238000001727 in vivo Methods 0.000 description 3
• 238000011534 incubation Methods 0.000 description 3
• 208000027866 inflammatory disease Diseases 0.000 description 3
• 229960000598 infliximab Drugs 0.000 description 3
• 210000005024 intraepithelial lymphocyte Anatomy 0.000 description 3
• 238000007912 intraperitoneal administration Methods 0.000 description 3
• 238000011068 loading method Methods 0.000 description 3
• 210000004698 lymphocyte Anatomy 0.000 description 3
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 3
• 238000010841 mRNA extraction Methods 0.000 description 3
• 238000005259 measurement Methods 0.000 description 3
• 238000002844 melting Methods 0.000 description 3
• 230000008018 melting Effects 0.000 description 3
• 229960001428 mercaptopurine Drugs 0.000 description 3
• 208000008275 microscopic colitis Diseases 0.000 description 3
• 230000007935 neutral effect Effects 0.000 description 3
• 210000000440 neutrophil Anatomy 0.000 description 3
• 239000012188 paraffin wax Substances 0.000 description 3
• 238000002823 phage display Methods 0.000 description 3
• 239000013641 positive control Substances 0.000 description 3
• 238000004393 prognosis Methods 0.000 description 3
• 230000005180 public health Effects 0.000 description 3
• 230000000171 quenching effect Effects 0.000 description 3
• 238000003127 radioimmunoassay Methods 0.000 description 3
• 230000008399 response to wounding Effects 0.000 description 3
• 230000011664 signaling Effects 0.000 description 3
• 210000000813 small intestine Anatomy 0.000 description 3
• 239000007787 solid Substances 0.000 description 3
• 238000007920 subcutaneous administration Methods 0.000 description 3
• 238000013518 transcription Methods 0.000 description 3
• 230000004580 weight loss Effects 0.000 description 3
• GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 2
• 102000006739 11-beta-Hydroxysteroid Dehydrogenase Type 2 Human genes 0.000 description 2
• 108010086356 11-beta-Hydroxysteroid Dehydrogenase Type 2 Proteins 0.000 description 2
• GANZODCWZFAEGN-UHFFFAOYSA-N 5-mercapto-2-nitro-benzoic acid Chemical compound OC(=O)C1=CC(S)=CC=C1[N+]([O-])=O GANZODCWZFAEGN-UHFFFAOYSA-N 0.000 description 2
• 108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 2
• 208000004998 Abdominal Pain Diseases 0.000 description 2
• 101710096365 Adhesion G-protein coupled receptor F1 Proteins 0.000 description 2
• 102100026443 Adhesion G-protein coupled receptor F1 Human genes 0.000 description 2
• 101710193393 Alpha-defensin 5 Proteins 0.000 description 2
• 102000019384 Aquaporin 9 Human genes 0.000 description 2
• 108050006914 Aquaporin 9 Proteins 0.000 description 2
• BHSYMWWMVRPCPA-CYDGBPFRSA-N Arg-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCN=C(N)N BHSYMWWMVRPCPA-CYDGBPFRSA-N 0.000 description 2
• 208000006820 Arthralgia Diseases 0.000 description 2
• 206010003445 Ascites Diseases 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 241000972773 Aulopiformes Species 0.000 description 2
• 102100021662 Baculoviral IAP repeat-containing protein 3 Human genes 0.000 description 2
• 101710177962 Baculoviral IAP repeat-containing protein 3 Proteins 0.000 description 2
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
• 102100036189 C-X-C motif chemokine 3 Human genes 0.000 description 2
• 102000018803 Calgranulin A Human genes 0.000 description 2
• 108010052500 Calgranulin A Proteins 0.000 description 2
• 108010052495 Calgranulin B Proteins 0.000 description 2
• 241000283707 Capra Species 0.000 description 2
• 102100035904 Caspase-1 Human genes 0.000 description 2
• 102100024931 Caspase-14 Human genes 0.000 description 2
• 102100038916 Caspase-5 Human genes 0.000 description 2
• 102000018704 Chitinase-3-Like Protein 1 Human genes 0.000 description 2
• 108010066813 Chitinase-3-Like Protein 1 Proteins 0.000 description 2
• 102100034622 Complement factor B Human genes 0.000 description 2
• 108091035707 Consensus sequence Proteins 0.000 description 2
• 108091029523 CpG island Proteins 0.000 description 2
• 230000004544 DNA amplification Effects 0.000 description 2
• 239000003298 DNA probe Substances 0.000 description 2
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
• 102100031262 Deleted in malignant brain tumors 1 protein Human genes 0.000 description 2
• 206010012741 Diarrhoea haemorrhagic Diseases 0.000 description 2
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
• 102100034597 E3 ubiquitin-protein ligase TRIM22 Human genes 0.000 description 2
• 102100023882 Endoribonuclease ZC3H12A Human genes 0.000 description 2
• 241000588724 Escherichia coli Species 0.000 description 2
• 241000724791 Filamentous phage Species 0.000 description 2
• 102000013382 Gelatinases Human genes 0.000 description 2
• 108010026132 Gelatinases Proteins 0.000 description 2
• 108090000079 Glucocorticoid Receptors Proteins 0.000 description 2
• 102100033417 Glucocorticoid receptor Human genes 0.000 description 2
• 102000049982 HMGA2 Human genes 0.000 description 2
• 108700039143 HMGA2 Proteins 0.000 description 2
• 102100038719 Histone deacetylase 7 Human genes 0.000 description 2
• 101150073387 Hmga2 gene Proteins 0.000 description 2
• 102100023830 Homeobox protein EMX2 Human genes 0.000 description 2
• 102100030307 Homeobox protein Hox-A13 Human genes 0.000 description 2
• 102100021088 Homeobox protein Hox-B13 Human genes 0.000 description 2
• 101000718228 Homo sapiens Adhesion G-protein coupled receptor F1 Proteins 0.000 description 2
• 101000652570 Homo sapiens Antigen peptide transporter 1 Proteins 0.000 description 2
• 101000652582 Homo sapiens Antigen peptide transporter 2 Proteins 0.000 description 2
• 101000771413 Homo sapiens Aquaporin-9 Proteins 0.000 description 2
• 101000896157 Homo sapiens Baculoviral IAP repeat-containing protein 2 Proteins 0.000 description 2
• 101000903615 Homo sapiens Basic leucine zipper transcriptional factor ATF-like 2 Proteins 0.000 description 2
• 101000947193 Homo sapiens C-X-C motif chemokine 3 Proteins 0.000 description 2
• 101100005959 Homo sapiens CFB gene Proteins 0.000 description 2
• 101000761467 Homo sapiens Caspase-14 Proteins 0.000 description 2
• 101000710032 Homo sapiens Complement factor B Proteins 0.000 description 2
• 101100223911 Homo sapiens DHX57 gene Proteins 0.000 description 2
• 101000976212 Homo sapiens Endoribonuclease ZC3H12A Proteins 0.000 description 2
• 101000862396 Homo sapiens Follicle-stimulating hormone receptor Proteins 0.000 description 2
• 101000968028 Homo sapiens HLA class II histocompatibility antigen, DRB1 beta chain Proteins 0.000 description 2
• 101000986379 Homo sapiens High mobility group protein HMGI-C Proteins 0.000 description 2
• 101001048970 Homo sapiens Homeobox protein EMX2 Proteins 0.000 description 2
• 101001041145 Homo sapiens Homeobox protein Hox-B13 Proteins 0.000 description 2
• 101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 description 2
• 101001076430 Homo sapiens Interleukin-13 Proteins 0.000 description 2
• 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 2
• 101001033279 Homo sapiens Interleukin-3 Proteins 0.000 description 2
• 101001002709 Homo sapiens Interleukin-4 Proteins 0.000 description 2
• 101000960969 Homo sapiens Interleukin-5 Proteins 0.000 description 2
• 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 description 2
• 101001022948 Homo sapiens LIM domain-binding protein 2 Proteins 0.000 description 2
• 101000581803 Homo sapiens Lithostathine-1-beta Proteins 0.000 description 2
• 101000956614 Homo sapiens Ly6/PLAUR domain-containing protein 5 Proteins 0.000 description 2
• 101000620359 Homo sapiens Melanocyte protein PMEL Proteins 0.000 description 2
• 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 description 2
• 101000969697 Homo sapiens Multiple PDZ domain protein Proteins 0.000 description 2
• 101001023833 Homo sapiens Neutrophil gelatinase-associated lipocalin Proteins 0.000 description 2
• 101001109700 Homo sapiens Nuclear receptor subfamily 4 group A member 1 Proteins 0.000 description 2
• 101000734351 Homo sapiens PDZ and LIM domain protein 1 Proteins 0.000 description 2
• 101000614347 Homo sapiens Prolyl 4-hydroxylase subunit alpha-2 Proteins 0.000 description 2
• 101000821881 Homo sapiens Protein S100-P Proteins 0.000 description 2
• 101001072231 Homo sapiens Protocadherin-17 Proteins 0.000 description 2
• 101100467488 Homo sapiens RAD50 gene Proteins 0.000 description 2
• 101000713272 Homo sapiens Solute carrier family 22 member 4 Proteins 0.000 description 2
• 101000713288 Homo sapiens Solute carrier family 22 member 5 Proteins 0.000 description 2
• 101000663002 Homo sapiens TNFAIP3-interacting protein 3 Proteins 0.000 description 2
• 101001074042 Homo sapiens Transcriptional activator GLI3 Proteins 0.000 description 2
• 101000712663 Homo sapiens Transforming growth factor beta-3 proprotein Proteins 0.000 description 2
• 101000760439 Homo sapiens UNC5C-like protein Proteins 0.000 description 2
• 101000964436 Homo sapiens Z-DNA-binding protein 1 Proteins 0.000 description 2
• 101100545173 Homo sapiens ZC3H12A gene Proteins 0.000 description 2
• 101001074048 Homo sapiens Zinc finger protein GLI1 Proteins 0.000 description 2
• 101000685839 Homo sapiens Zinc transporter ZIP5 Proteins 0.000 description 2
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
• 102000013463 Immunoglobulin Light Chains Human genes 0.000 description 2
• 108010065825 Immunoglobulin Light Chains Proteins 0.000 description 2
• 108010072621 Interleukin-1 Receptor-Associated Kinases Proteins 0.000 description 2
• 102000010790 Interleukin-3 Receptors Human genes 0.000 description 2
• 108010038452 Interleukin-3 Receptors Proteins 0.000 description 2
• 102000011782 Keratins Human genes 0.000 description 2
• 108010076876 Keratins Proteins 0.000 description 2
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
• 102000003960 Ligases Human genes 0.000 description 2
• 108090000364 Ligases Proteins 0.000 description 2
• 102100038486 Ly6/PLAUR domain-containing protein 5 Human genes 0.000 description 2
• 102000004055 Matrix metalloproteinase-19 Human genes 0.000 description 2
• 108090000587 Matrix metalloproteinase-19 Proteins 0.000 description 2
• 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 2
• 108091027974 Mature messenger RNA Proteins 0.000 description 2
• 102100022430 Melanocyte protein PMEL Human genes 0.000 description 2
• 102000011202 Member 2 Subfamily B ATP Binding Cassette Transporter Human genes 0.000 description 2
• 108090000375 Mineralocorticoid Receptors Proteins 0.000 description 2
• 102100021316 Mineralocorticoid receptor Human genes 0.000 description 2
• 102100026907 Mitogen-activated protein kinase kinase kinase 8 Human genes 0.000 description 2
• 102100035405 Neutrophil gelatinase-associated lipocalin Human genes 0.000 description 2
• 108091006764 Organic cation transporters Proteins 0.000 description 2
• 102000004316 Oxidoreductases Human genes 0.000 description 2
• 108090000854 Oxidoreductases Proteins 0.000 description 2
• 101710121673 PDZ and LIM domain protein 1 Proteins 0.000 description 2
• 102000035195 Peptidases Human genes 0.000 description 2
• 108091005804 Peptidases Proteins 0.000 description 2
• 102100029354 Phenylalanine-tRNA ligase, mitochondrial Human genes 0.000 description 2
• 101710157834 Protocadherin-17 Proteins 0.000 description 2
• 102100036391 Protocadherin-17 Human genes 0.000 description 2
• 206010037660 Pyrexia Diseases 0.000 description 2
• 238000010802 RNA extraction kit Methods 0.000 description 2
• 108020004511 Recombinant DNA Proteins 0.000 description 2
• 108091058557 SILV Proteins 0.000 description 2
• 108091006946 SLC39A5 Proteins 0.000 description 2
• 102100032007 Serum amyloid A-2 protein Human genes 0.000 description 2
• 102100022459 Sterile alpha motif domain-containing protein 9-like Human genes 0.000 description 2
• 101710137500 T7 RNA polymerase Proteins 0.000 description 2
• 101710098080 Teratocarcinoma-derived growth factor Proteins 0.000 description 2
• 102100031294 Thymic stromal lymphopoietin Human genes 0.000 description 2
• 102100035559 Transcriptional activator GLI3 Human genes 0.000 description 2
• 241000700605 Viruses Species 0.000 description 2
• 102100023142 Zinc transporter ZIP5 Human genes 0.000 description 2
• 230000001594 aberrant effect Effects 0.000 description 2
• 230000005856 abnormality Effects 0.000 description 2
• 150000007513 acids Chemical class 0.000 description 2
• 230000004913 activation Effects 0.000 description 2
• 208000026816 acute arthritis Diseases 0.000 description 2
• 230000010398 acute inflammatory response Effects 0.000 description 2
• 238000007792 addition Methods 0.000 description 2
• 230000001919 adrenal effect Effects 0.000 description 2
• 238000001042 affinity chromatography Methods 0.000 description 2
• 230000009824 affinity maturation Effects 0.000 description 2
• 235000004279 alanine Nutrition 0.000 description 2
• 238000012867 alanine scanning Methods 0.000 description 2
• 208000007502 anemia Diseases 0.000 description 2
• 230000003110 anti-inflammatory effect Effects 0.000 description 2
• 230000000890 antigenic effect Effects 0.000 description 2
• 239000002787 antisense oligonuctleotide Substances 0.000 description 2
• 210000000436 anus Anatomy 0.000 description 2
• 229940072224 asacol Drugs 0.000 description 2
• 230000001174 ascending effect Effects 0.000 description 2
• 210000003719 b-lymphocyte Anatomy 0.000 description 2
• 230000001580 bacterial effect Effects 0.000 description 2
• 230000004888 barrier function Effects 0.000 description 2
• 230000009286 beneficial effect Effects 0.000 description 2
• 238000003766 bioinformatics method Methods 0.000 description 2
• 210000004369 blood Anatomy 0.000 description 2
• 239000008280 blood Substances 0.000 description 2
• 229940098773 bovine serum albumin Drugs 0.000 description 2
• 239000006227 byproduct Substances 0.000 description 2
• AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
• 238000004364 calculation method Methods 0.000 description 2
• 201000011510 cancer Diseases 0.000 description 2
• 210000004534 cecum Anatomy 0.000 description 2
• 230000024245 cell differentiation Effects 0.000 description 2
• 238000012512 characterization method Methods 0.000 description 2
• MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
• 238000010367 cloning Methods 0.000 description 2
• 230000000052 comparative effect Effects 0.000 description 2
• 230000001447 compensatory effect Effects 0.000 description 2
• 238000012875 competitive assay Methods 0.000 description 2
• 230000002860 competitive effect Effects 0.000 description 2
• 238000012790 confirmation Methods 0.000 description 2
• 238000007796 conventional method Methods 0.000 description 2
• 230000002596 correlated effect Effects 0.000 description 2
• 239000003431 cross linking reagent Substances 0.000 description 2
• 239000013078 crystal Substances 0.000 description 2
• 150000001945 cysteines Chemical class 0.000 description 2
• 230000007123 defense Effects 0.000 description 2
• 238000000432 density-gradient centrifugation Methods 0.000 description 2
• 229960000633 dextran sulfate Drugs 0.000 description 2
• 229960005156 digoxin Drugs 0.000 description 2
• 239000000539 dimer Substances 0.000 description 2
• 230000009266 disease activity Effects 0.000 description 2
• 208000022602 disease susceptibility Diseases 0.000 description 2
• 238000009826 distribution Methods 0.000 description 2
• 150000004662 dithiols Chemical class 0.000 description 2
• 230000009977 dual effect Effects 0.000 description 2
• 210000001198 duodenum Anatomy 0.000 description 2
• 239000012636 effector Substances 0.000 description 2
• 230000007613 environmental effect Effects 0.000 description 2
• 235000013305 food Nutrition 0.000 description 2
• 239000000499 gel Substances 0.000 description 2
• 238000001502 gel electrophoresis Methods 0.000 description 2
• 238000007429 general method Methods 0.000 description 2
• 230000000762 glandular Effects 0.000 description 2
• 108010021685 homeobox protein HOXA13 Proteins 0.000 description 2
• 230000013632 homeostatic process Effects 0.000 description 2
• 102000055600 human ADGRF1 Human genes 0.000 description 2
• 102000055680 human AQP9 Human genes 0.000 description 2
• 102000057931 human BIRC2 Human genes 0.000 description 2
• 102000050388 human CASP5 Human genes 0.000 description 2
• 102000048448 human CASP8 Human genes 0.000 description 2
• 102000045734 human CCL20 Human genes 0.000 description 2
• 102000046157 human CSF2 Human genes 0.000 description 2
• 102000045451 human DMBT1 Human genes 0.000 description 2
• 102000057266 human FCGR3A Human genes 0.000 description 2
• 102000046113 human FSHR Human genes 0.000 description 2
• 102000045911 human HDAC7 Human genes 0.000 description 2
• 102000051789 human HMGA2 Human genes 0.000 description 2
• 102000055222 human IL1B Human genes 0.000 description 2
• 102000052205 human IL2RA Human genes 0.000 description 2
• 102000055276 human IL3 Human genes 0.000 description 2
• 102000055229 human IL4 Human genes 0.000 description 2
• 102000055228 human IL5 Human genes 0.000 description 2
• 102000046801 human IRAK3 Human genes 0.000 description 2
• 102000051616 human KCND3 Human genes 0.000 description 2
• 102000047202 human LCN2 Human genes 0.000 description 2
• 102000055570 human LDB2 Human genes 0.000 description 2
• 102000049920 human MAP3K8 Human genes 0.000 description 2
• 102000056609 human MMP3 Human genes 0.000 description 2
• 102000052074 human MMP7 Human genes 0.000 description 2
• 102000045747 human MPDZ Human genes 0.000 description 2
• 102000047925 human NEU4 Human genes 0.000 description 2
• 102000050213 human OLFM4 Human genes 0.000 description 2
• 102000051269 human P4HA2 Human genes 0.000 description 2
• 102000056620 human PDLIM4 Human genes 0.000 description 2
• 102000053076 human PMEL Human genes 0.000 description 2
• 102000050695 human SAA2 Human genes 0.000 description 2
• 102000050184 human SAMD9L Human genes 0.000 description 2
• 102000056755 human SLC22A4 Human genes 0.000 description 2
• 102000045801 human SLC22A5 Human genes 0.000 description 2
• 102000051421 human SLC39A5 Human genes 0.000 description 2
• 102000057131 human TAP1 Human genes 0.000 description 2
• 102000054264 human TAP2 Human genes 0.000 description 2
• 102000053431 human TGFB3 Human genes 0.000 description 2
• 102000045717 human TLR4 Human genes 0.000 description 2
• 102000056290 human TNIP3 Human genes 0.000 description 2
• 102000057220 human TRIM22 Human genes 0.000 description 2
• 102000045535 human TSLP Human genes 0.000 description 2
• 102000046263 human UNC5CL Human genes 0.000 description 2
• 102000057824 human ZBP1 Human genes 0.000 description 2
• 102000050964 human ZC3H12A Human genes 0.000 description 2
• 102000019207 human interleukin-13 Human genes 0.000 description 2
• 102000006777 human protocadherin 17 Human genes 0.000 description 2
• 229910052739 hydrogen Inorganic materials 0.000 description 2
• 239000001257 hydrogen Substances 0.000 description 2
• 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
• FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
• 210000000987 immune system Anatomy 0.000 description 2
• 230000036039 immunity Effects 0.000 description 2
• 230000003053 immunization Effects 0.000 description 2
• 238000002649 immunization Methods 0.000 description 2
• 229940127121 immunoconjugate Drugs 0.000 description 2
• 229940072221 immunoglobulins Drugs 0.000 description 2
• 238000010324 immunological assay Methods 0.000 description 2
• 230000001976 improved effect Effects 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• 238000002347 injection Methods 0.000 description 2
• 239000007924 injection Substances 0.000 description 2
• 230000002452 interceptive effect Effects 0.000 description 2
• 238000005304 joining Methods 0.000 description 2
• 210000000265 leukocyte Anatomy 0.000 description 2
• 230000003908 liver function Effects 0.000 description 2
• 210000001165 lymph node Anatomy 0.000 description 2
• 210000002540 macrophage Anatomy 0.000 description 2
• 238000013507 mapping Methods 0.000 description 2
• 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
• 229960004963 mesalazine Drugs 0.000 description 2
• 210000000713 mesentery Anatomy 0.000 description 2
• 238000007855 methylation-specific PCR Methods 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 230000017074 necrotic cell death Effects 0.000 description 2
• 230000003448 neutrophilic effect Effects 0.000 description 2
• 229910052757 nitrogen Inorganic materials 0.000 description 2
• 238000011903 nutritional therapy Methods 0.000 description 2
• 238000005457 optimization Methods 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 230000001575 pathological effect Effects 0.000 description 2
• 230000035778 pathophysiological process Effects 0.000 description 2
• 229960002087 pertuzumab Drugs 0.000 description 2
• 229960005205 prednisolone Drugs 0.000 description 2
• OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 2
• 229960004618 prednisone Drugs 0.000 description 2
• XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 2
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
• 238000010880 proctocolectomy Methods 0.000 description 2
• 230000000770 proinflammatory effect Effects 0.000 description 2
• 235000019419 proteases Nutrition 0.000 description 2
• 230000004952 protein activity Effects 0.000 description 2
• 238000000159 protein binding assay Methods 0.000 description 2
• 238000004445 quantitative analysis Methods 0.000 description 2
• 238000013139 quantization Methods 0.000 description 2
• 238000010791 quenching Methods 0.000 description 2
• 238000002708 random mutagenesis Methods 0.000 description 2
• 230000007115 recruitment Effects 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 229940116176 remicade Drugs 0.000 description 2
• 230000008439 repair process Effects 0.000 description 2
• 206010039073 rheumatoid arthritis Diseases 0.000 description 2
• 235000019515 salmon Nutrition 0.000 description 2
• 210000000582 semen Anatomy 0.000 description 2
• 230000035945 sensitivity Effects 0.000 description 2
• 239000001488 sodium phosphate Substances 0.000 description 2
• 229910000162 sodium phosphate Inorganic materials 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 210000002784 stomach Anatomy 0.000 description 2
• 238000010254 subcutaneous injection Methods 0.000 description 2
• 239000007929 subcutaneous injection Substances 0.000 description 2
• KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
• GECHUMIMRBOMGK-UHFFFAOYSA-N sulfapyridine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CC=CC=N1 GECHUMIMRBOMGK-UHFFFAOYSA-N 0.000 description 2
• 229960002211 sulfapyridine Drugs 0.000 description 2
• 239000013589 supplement Substances 0.000 description 2
• 210000005222 synovial tissue Anatomy 0.000 description 2
• 229940037128 systemic glucocorticoids Drugs 0.000 description 2
• 231100000331 toxic Toxicity 0.000 description 2
• 230000002588 toxic effect Effects 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 210000003384 transverse colon Anatomy 0.000 description 2
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
• 230000036269 ulceration Effects 0.000 description 2
• 210000002700 urine Anatomy 0.000 description 2
• OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
• AWNBSWDIOCXWJW-WTOYTKOKSA-N (2r)-n-[(2s)-1-[[(2s)-1-(2-aminoethylamino)-1-oxopropan-2-yl]amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-n'-hydroxy-2-(2-methylpropyl)butanediamide Chemical compound C1=CC=CC2=CC(C[C@H](NC(=O)[C@@H](CC(=O)NO)CC(C)C)C(=O)N[C@@H](C)C(=O)NCCN)=CC=C21 AWNBSWDIOCXWJW-WTOYTKOKSA-N 0.000 description 1
• 101150028074 2 gene Proteins 0.000 description 1
• KGLPWQKSKUVKMJ-UHFFFAOYSA-N 2,3-dihydrophthalazine-1,4-dione Chemical class C1=CC=C2C(=O)NNC(=O)C2=C1 KGLPWQKSKUVKMJ-UHFFFAOYSA-N 0.000 description 1
• FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
• OBWSOTREAMFOCQ-UHFFFAOYSA-N 4-(4-amino-3,5-dimethylphenyl)-2,6-dimethylaniline;hydrochloride Chemical compound Cl.CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 OBWSOTREAMFOCQ-UHFFFAOYSA-N 0.000 description 1
• XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
• QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
• TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
• LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical group CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
• 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
• 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
• 102100021206 60S ribosomal protein L19 Human genes 0.000 description 1
• 102100036614 ABC-type organic anion transporter ABCA8 Human genes 0.000 description 1
• 101150092476 ABCA1 gene Proteins 0.000 description 1
• 101150119038 ABCB1 gene Proteins 0.000 description 1
• 108700005241 ATP Binding Cassette Transporter 1 Proteins 0.000 description 1
• 102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 1
• 102100028187 ATP-binding cassette sub-family C member 6 Human genes 0.000 description 1
• 102100020979 ATP-binding cassette sub-family F member 1 Human genes 0.000 description 1
• 102100022654 ATP-binding cassette sub-family F member 2 Human genes 0.000 description 1
• 206010000077 Abdominal mass Diseases 0.000 description 1
• 206010058040 Abdominal sepsis Diseases 0.000 description 1
• 206010000097 Abdominal tenderness Diseases 0.000 description 1
• WQVFQXXBNHHPLX-ZKWXMUAHSA-N Ala-Ala-His Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O WQVFQXXBNHHPLX-ZKWXMUAHSA-N 0.000 description 1
• YYSWCHMLFJLLBJ-ZLUOBGJFSA-N Ala-Ala-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 1
• 208000004881 Amebiasis Diseases 0.000 description 1
• 206010001980 Amoebiasis Diseases 0.000 description 1
• 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
• 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
• 108020005544 Antisense RNA Proteins 0.000 description 1
• PTVGLOCPAVYPFG-CIUDSAMLSA-N Arg-Gln-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O PTVGLOCPAVYPFG-CIUDSAMLSA-N 0.000 description 1
• 241000796533 Arna Species 0.000 description 1
• PTNFNTOBUDWHNZ-GUBZILKMSA-N Asn-Arg-Met Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(O)=O PTNFNTOBUDWHNZ-GUBZILKMSA-N 0.000 description 1
• LJUOLNXOWSWGKF-ACZMJKKPSA-N Asn-Asn-Glu Chemical compound C(CC(=O)O)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N LJUOLNXOWSWGKF-ACZMJKKPSA-N 0.000 description 1
• KHCNTVRVAYCPQE-CIUDSAMLSA-N Asn-Lys-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O KHCNTVRVAYCPQE-CIUDSAMLSA-N 0.000 description 1
• FANQWNCPNFEPGZ-WHFBIAKZSA-N Asp-Asp-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O FANQWNCPNFEPGZ-WHFBIAKZSA-N 0.000 description 1
• 101710192393 Attachment protein G3P Proteins 0.000 description 1
• 108090000363 Bacterial Luciferases Proteins 0.000 description 1
• 102100023006 Basic leucine zipper transcriptional factor ATF-like 2 Human genes 0.000 description 1
• LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 241001086826 Branta bernicla Species 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
• 102100036842 C-C motif chemokine 19 Human genes 0.000 description 1
• 102100036850 C-C motif chemokine 23 Human genes 0.000 description 1
• 241000252983 Caecum Species 0.000 description 1
• 101710169873 Capsid protein G8P Proteins 0.000 description 1
• 241001092081 Carpenteria Species 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• 108090000426 Caspase-1 Proteins 0.000 description 1
• 108090000994 Catalytic RNA Proteins 0.000 description 1
• 102000053642 Catalytic RNA Human genes 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 108091006146 Channels Proteins 0.000 description 1
• 102000009410 Chemokine receptor Human genes 0.000 description 1
• 108050000299 Chemokine receptor Proteins 0.000 description 1
• 102000012286 Chitinases Human genes 0.000 description 1
• 108010022172 Chitinases Proteins 0.000 description 1
• 108010077544 Chromatin Proteins 0.000 description 1
• 206010009657 Clostridium difficile colitis Diseases 0.000 description 1
• 108020004705 Codon Proteins 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 208000027205 Congenital disease Diseases 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• 241000699802 Cricetulus griseus Species 0.000 description 1
• 229930105110 Cyclosporin A Natural products 0.000 description 1
• 102100028183 Cytohesin-interacting protein Human genes 0.000 description 1
• IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
• 239000003155 DNA primer Substances 0.000 description 1
• 102100039116 DNA repair protein RAD50 Human genes 0.000 description 1
• 238000001712 DNA sequencing Methods 0.000 description 1
• 241000238557 Decapoda Species 0.000 description 1
• CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
• 102000016911 Deoxyribonucleases Human genes 0.000 description 1
• 108010053770 Deoxyribonucleases Proteins 0.000 description 1
• 108700029231 Developmental Genes Proteins 0.000 description 1
• 206010012735 Diarrhoea Diseases 0.000 description 1
• LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
• 101100234002 Drosophila melanogaster Shal gene Proteins 0.000 description 1
• 206010058314 Dysplasia Diseases 0.000 description 1
• 102100023471 E-selectin Human genes 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 108010042407 Endonucleases Proteins 0.000 description 1
• 108010067770 Endopeptidase K Proteins 0.000 description 1
• 238000012327 Endoscopic diagnosis Methods 0.000 description 1
• 102100038595 Estrogen receptor Human genes 0.000 description 1
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
• 229910052693 Europium Inorganic materials 0.000 description 1
• 208000010201 Exanthema Diseases 0.000 description 1
• 108091060211 Expressed sequence tag Proteins 0.000 description 1
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
• 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
• 102100031706 Fibroblast growth factor 1 Human genes 0.000 description 1
• 206010016654 Fibrosis Diseases 0.000 description 1
• 229920001917 Ficoll Polymers 0.000 description 1
• 108090000331 Firefly luciferases Proteins 0.000 description 1
• BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
• 102000017934 GABA-B receptor Human genes 0.000 description 1
• 108060003377 GABA-B receptor Proteins 0.000 description 1
• 108010015133 Galactose oxidase Proteins 0.000 description 1
• 208000005577 Gastroenteritis Diseases 0.000 description 1
• 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
• BPDVTFBJZNBHEU-HGNGGELXSA-N Glu-Ala-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 BPDVTFBJZNBHEU-HGNGGELXSA-N 0.000 description 1
• NUSWUSKZRCGFEX-FXQIFTODSA-N Glu-Glu-Cys Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(O)=O NUSWUSKZRCGFEX-FXQIFTODSA-N 0.000 description 1
• 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
• 102100022624 Glucoamylase Human genes 0.000 description 1
• 108010015776 Glucose oxidase Proteins 0.000 description 1
• 239000004366 Glucose oxidase Substances 0.000 description 1
• 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
• SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
• 244000068988 Glycine max Species 0.000 description 1
• 235000010469 Glycine max Nutrition 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
• 208000031886 HIV Infections Diseases 0.000 description 1
• 208000037357 HIV infectious disease Diseases 0.000 description 1
• 101710197836 HLA class I histocompatibility antigen, alpha chain G Proteins 0.000 description 1
• 102000003693 Hedgehog Proteins Human genes 0.000 description 1
• 108090000031 Hedgehog Proteins Proteins 0.000 description 1
• 102100035960 Hedgehog-interacting protein Human genes 0.000 description 1
• 101710164669 Hedgehog-interacting protein Proteins 0.000 description 1
• 102000001554 Hemoglobins Human genes 0.000 description 1
• 108010054147 Hemoglobins Proteins 0.000 description 1
• 101001105789 Homo sapiens 60S ribosomal protein L19 Proteins 0.000 description 1
• 101000929669 Homo sapiens ABC-type organic anion transporter ABCA8 Proteins 0.000 description 1
• 101100056788 Homo sapiens ARRDC5 gene Proteins 0.000 description 1
• 101000986621 Homo sapiens ATP-binding cassette sub-family C member 6 Proteins 0.000 description 1
• 101000783783 Homo sapiens ATP-binding cassette sub-family F member 1 Proteins 0.000 description 1
• 101000823289 Homo sapiens ATP-binding cassette sub-family F member 2 Proteins 0.000 description 1
• 101000713106 Homo sapiens C-C motif chemokine 19 Proteins 0.000 description 1
• 101000713081 Homo sapiens C-C motif chemokine 23 Proteins 0.000 description 1
• 101100005263 Homo sapiens CASP1 gene Proteins 0.000 description 1
• 101000859758 Homo sapiens Cartilage-associated protein Proteins 0.000 description 1
• 101000715398 Homo sapiens Caspase-1 Proteins 0.000 description 1
• 101000883515 Homo sapiens Chitinase-3-like protein 1 Proteins 0.000 description 1
• 101000916686 Homo sapiens Cytohesin-interacting protein Proteins 0.000 description 1
• 101000743929 Homo sapiens DNA repair protein RAD50 Proteins 0.000 description 1
• 101000622123 Homo sapiens E-selectin Proteins 0.000 description 1
• 101000726740 Homo sapiens Homeobox protein cut-like 1 Proteins 0.000 description 1
• 101000598002 Homo sapiens Interferon regulatory factor 1 Proteins 0.000 description 1
• 101001034844 Homo sapiens Interferon-induced transmembrane protein 1 Proteins 0.000 description 1
• 101000677891 Homo sapiens Iron-sulfur clusters transporter ABCB7, mitochondrial Proteins 0.000 description 1
• 101100243645 Homo sapiens PDGFRA gene Proteins 0.000 description 1
• 101000947178 Homo sapiens Platelet basic protein Proteins 0.000 description 1
• 101001001272 Homo sapiens Prostatic acid phosphatase Proteins 0.000 description 1
• 101000761460 Homo sapiens Protein CASP Proteins 0.000 description 1
• 101000869690 Homo sapiens Protein S100-A8 Proteins 0.000 description 1
• 101000864681 Homo sapiens Putative ATP-dependent RNA helicase DHX57 Proteins 0.000 description 1
• 101001019136 Homo sapiens Putative methyltransferase-like protein 7A Proteins 0.000 description 1
• 101000869480 Homo sapiens Serum amyloid A-1 protein Proteins 0.000 description 1
• 101000651299 Homo sapiens Sprouty-related, EVH1 domain-containing protein 2 Proteins 0.000 description 1
• 101000796134 Homo sapiens Thymidine phosphorylase Proteins 0.000 description 1
• 101000939535 Homo sapiens UDP-glucuronosyltransferase 2B10 Proteins 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
• 108091058560 IL8 Proteins 0.000 description 1
• IOVUXUSIGXCREV-DKIMLUQUSA-N Ile-Leu-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IOVUXUSIGXCREV-DKIMLUQUSA-N 0.000 description 1
• IPFKIGNDTUOFAF-CYDGBPFRSA-N Ile-Val-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IPFKIGNDTUOFAF-CYDGBPFRSA-N 0.000 description 1
• 208000029462 Immunodeficiency disease Diseases 0.000 description 1
• 108700005091 Immunoglobulin Genes Proteins 0.000 description 1
• 102100040061 Indoleamine 2,3-dioxygenase 1 Human genes 0.000 description 1
• 101710120843 Indoleamine 2,3-dioxygenase 1 Proteins 0.000 description 1
• 229930010555 Inosine Natural products 0.000 description 1
• UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
• 102000004289 Interferon regulatory factor 1 Human genes 0.000 description 1
• 108090000890 Interferon regulatory factor 1 Proteins 0.000 description 1
• 102100036981 Interferon regulatory factor 1 Human genes 0.000 description 1
• 102100040021 Interferon-induced transmembrane protein 1 Human genes 0.000 description 1
• 102000006940 Interleukin-1 Receptor-Associated Kinases Human genes 0.000 description 1
• 102000013462 Interleukin-12 Human genes 0.000 description 1
• 108010065805 Interleukin-12 Proteins 0.000 description 1
• 102000003816 Interleukin-13 Human genes 0.000 description 1
• 108090000176 Interleukin-13 Proteins 0.000 description 1
• 108050003558 Interleukin-17 Proteins 0.000 description 1
• 102000013691 Interleukin-17 Human genes 0.000 description 1
• 102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
• 108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
• 108010065637 Interleukin-23 Proteins 0.000 description 1
• 102100036705 Interleukin-23 subunit alpha Human genes 0.000 description 1
• 102000000646 Interleukin-3 Human genes 0.000 description 1
• 108010002386 Interleukin-3 Proteins 0.000 description 1
• 102000004388 Interleukin-4 Human genes 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 102000000743 Interleukin-5 Human genes 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• 102100021504 Iron-sulfur clusters transporter ABCB7, mitochondrial Human genes 0.000 description 1
• 206010023232 Joint swelling Diseases 0.000 description 1
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• 102100038609 Lactoperoxidase Human genes 0.000 description 1
• 108010023244 Lactoperoxidase Proteins 0.000 description 1
• LCPYQJIKPJDLLB-UWVGGRQHSA-N Leu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC(C)C LCPYQJIKPJDLLB-UWVGGRQHSA-N 0.000 description 1
• 108010051335 Lipocalin-2 Proteins 0.000 description 1
• 108010014691 Lithostathine Proteins 0.000 description 1
• 102000016997 Lithostathine Human genes 0.000 description 1
• 102100027338 Lithostathine-1-beta Human genes 0.000 description 1
• 102100029193 Low affinity immunoglobulin gamma Fc region receptor III-A Human genes 0.000 description 1
• 108060001084 Luciferase Proteins 0.000 description 1
• DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 101710125418 Major capsid protein Proteins 0.000 description 1
• 101710156564 Major tail protein Gp23 Proteins 0.000 description 1
• 102000013460 Malate Dehydrogenase Human genes 0.000 description 1
• 108010026217 Malate Dehydrogenase Proteins 0.000 description 1
• 238000000585 Mann–Whitney U test Methods 0.000 description 1
• 102000004318 Matrilysin Human genes 0.000 description 1
• 108090000855 Matrilysin Proteins 0.000 description 1
• 108010023335 Member 2 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
• 101000761459 Mesocricetus auratus Calcium-dependent serine proteinase Proteins 0.000 description 1
• 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 description 1
• 206010027476 Metastases Diseases 0.000 description 1
• FQISKWAFAHGMGT-SGJOWKDISA-M Methylprednisolone sodium succinate Chemical compound [Na+].C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(=O)CCC([O-])=O)CC[C@H]21 FQISKWAFAHGMGT-SGJOWKDISA-M 0.000 description 1
• 101710164353 Mitogen-activated protein kinase kinase kinase 8 Proteins 0.000 description 1
• 241000713869 Moloney murine leukemia virus Species 0.000 description 1
• 206010027951 Mood swings Diseases 0.000 description 1
• 241000713333 Mouse mammary tumor virus Species 0.000 description 1
• 206010028116 Mucosal inflammation Diseases 0.000 description 1
• 208000007101 Muscle Cramp Diseases 0.000 description 1
• NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 102100022679 Nuclear receptor subfamily 4 group A member 1 Human genes 0.000 description 1
• 102100026071 Olfactomedin-4 Human genes 0.000 description 1
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
• 108700020796 Oncogene Proteins 0.000 description 1
• 208000007117 Oral Ulcer Diseases 0.000 description 1
• 238000009004 PCR Kit Methods 0.000 description 1
• 238000002944 PCR assay Methods 0.000 description 1
• 108091008606 PDGF receptors Proteins 0.000 description 1
• 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
• 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
• 108090000526 Papain Proteins 0.000 description 1
• 241000599931 Paris quadrifolia Species 0.000 description 1
• 102000000017 Patched Receptors Human genes 0.000 description 1
• 108010069873 Patched Receptors Proteins 0.000 description 1
• 208000037273 Pathologic Processes Diseases 0.000 description 1
• 102000057297 Pepsin A Human genes 0.000 description 1
• 108090000284 Pepsin A Proteins 0.000 description 1
• 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 description 1
• 102100038831 Peroxisome proliferator-activated receptor alpha Human genes 0.000 description 1
• WEMYTDDMDBLPMI-DKIMLUQUSA-N Phe-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N WEMYTDDMDBLPMI-DKIMLUQUSA-N 0.000 description 1
• KIQUCMUULDXTAZ-HJOGWXRNSA-N Phe-Tyr-Tyr Chemical compound N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O KIQUCMUULDXTAZ-HJOGWXRNSA-N 0.000 description 1
• 102100033616 Phospholipid-transporting ATPase ABCA1 Human genes 0.000 description 1
• 108010004729 Phycoerythrin Proteins 0.000 description 1
• 102100036154 Platelet basic protein Human genes 0.000 description 1
• 102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 102000004257 Potassium Channel Human genes 0.000 description 1
• 102100033184 Potassium voltage-gated channel subfamily D member 3 Human genes 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 206010036774 Proctitis Diseases 0.000 description 1
• 101710156990 Protein S100-A9 Proteins 0.000 description 1
• 102100021494 Protein S100-P Human genes 0.000 description 1
• 108010026552 Proteome Proteins 0.000 description 1
• 208000003100 Pseudomembranous Enterocolitis Diseases 0.000 description 1
• 206010037128 Pseudomembranous colitis Diseases 0.000 description 1
• 102100030092 Putative ATP-dependent RNA helicase DHX57 Human genes 0.000 description 1
• 102100034758 Putative methyltransferase-like protein 7A Human genes 0.000 description 1
• 108091058544 REG family proteins Proteins 0.000 description 1
• 238000011530 RNeasy Mini Kit Methods 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 206010038063 Rectal haemorrhage Diseases 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 102220492414 Ribulose-phosphate 3-epimerase_H35A_mutation Human genes 0.000 description 1
• 102000037054 SLC-Transporter Human genes 0.000 description 1
• 108091006207 SLC-Transporter Proteins 0.000 description 1
• 108091006976 SLC40A1 Proteins 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 229920002684 Sepharose Polymers 0.000 description 1
• QMCDMHWAKMUGJE-IHRRRGAJSA-N Ser-Phe-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O QMCDMHWAKMUGJE-IHRRRGAJSA-N 0.000 description 1
• XZKQVQKUZMAADP-IMJSIDKUSA-N Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(O)=O XZKQVQKUZMAADP-IMJSIDKUSA-N 0.000 description 1
• DKGRNFUXVTYRAS-UBHSHLNASA-N Ser-Ser-Trp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O DKGRNFUXVTYRAS-UBHSHLNASA-N 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 108010071390 Serum Albumin Proteins 0.000 description 1
• 102000007562 Serum Albumin Human genes 0.000 description 1
• 244000166071 Shorea robusta Species 0.000 description 1
• 235000015076 Shorea robusta Nutrition 0.000 description 1
• 108050000174 Sialidase-4 Proteins 0.000 description 1
• 102000009324 Sialidase-4 Human genes 0.000 description 1
• 102100037729 Sialidase-4 Human genes 0.000 description 1
• BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
• 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
• 210000001744 T-lymphocyte Anatomy 0.000 description 1
• COYHRQWNJDJCNA-NUJDXYNKSA-N Thr-Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O COYHRQWNJDJCNA-NUJDXYNKSA-N 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 108010034949 Thyroglobulin Proteins 0.000 description 1
• 102000009843 Thyroglobulin Human genes 0.000 description 1
• 108010031374 Tissue Inhibitor of Metalloproteinase-1 Proteins 0.000 description 1
• 102000005353 Tissue Inhibitor of Metalloproteinase-1 Human genes 0.000 description 1
• 108090000631 Trypsin Proteins 0.000 description 1
• 102000004142 Trypsin Human genes 0.000 description 1
• 101710162629 Trypsin inhibitor Proteins 0.000 description 1
• 229940122618 Trypsin inhibitor Drugs 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 108010020713 Tth polymerase Proteins 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
• 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
• 102100040247 Tumor necrosis factor Human genes 0.000 description 1
• ARJASMXQBRNAGI-YESZJQIVSA-N Tyr-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N ARJASMXQBRNAGI-YESZJQIVSA-N 0.000 description 1
• 102100029634 UDP-glucuronosyltransferase 2B10 Human genes 0.000 description 1
• 102100029633 UDP-glucuronosyltransferase 2B15 Human genes 0.000 description 1
• 101710200683 UDP-glucuronosyltransferase 2B15 Proteins 0.000 description 1
• 102100040373 UDP-glucuronosyltransferase 2B17 Human genes 0.000 description 1
• 101710200687 UDP-glucuronosyltransferase 2B17 Proteins 0.000 description 1
• 101150032479 UNC-5 gene Proteins 0.000 description 1
• 108090000848 Ubiquitin Proteins 0.000 description 1
• 102000044159 Ubiquitin Human genes 0.000 description 1
• 108010092464 Urate Oxidase Proteins 0.000 description 1
• 108010046334 Urease Proteins 0.000 description 1
• 208000006038 Urogenital Abnormalities Diseases 0.000 description 1
• 101150117115 V gene Proteins 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• 102000013814 Wnt Human genes 0.000 description 1
• 108050003627 Wnt Proteins 0.000 description 1
• 102100033220 Xanthine oxidase Human genes 0.000 description 1
• 108010093894 Xanthine oxidase Proteins 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• 102220485457 Zinc finger protein GLI1_E1100Q_mutation Human genes 0.000 description 1
• 206010000269 abscess Diseases 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 239000011543 agarose gel Substances 0.000 description 1
• 230000004931 aggregating effect Effects 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• 229940037003 alum Drugs 0.000 description 1
• 229960003896 aminopterin Drugs 0.000 description 1
• 238000012197 amplification kit Methods 0.000 description 1
• 239000012491 analyte Substances 0.000 description 1
• 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 238000000137 annealing Methods 0.000 description 1
• 230000008485 antagonism Effects 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 229940121363 anti-inflammatory agent Drugs 0.000 description 1
• 239000002260 anti-inflammatory agent Substances 0.000 description 1
• 238000011861 anti-inflammatory therapy Methods 0.000 description 1
• 230000000845 anti-microbial effect Effects 0.000 description 1
• 230000000692 anti-sense effect Effects 0.000 description 1
• 238000011091 antibody purification Methods 0.000 description 1
• 210000000628 antibody-producing cell Anatomy 0.000 description 1
• 238000010913 antigen-directed enzyme pro-drug therapy Methods 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 238000002820 assay format Methods 0.000 description 1
• 230000001363 autoimmune Effects 0.000 description 1
• 108010028263 bacteriophage T3 RNA polymerase Proteins 0.000 description 1
• 229960004168 balsalazide Drugs 0.000 description 1
• IPOKCKJONYRRHP-FMQUCBEESA-N balsalazide Chemical compound C1=CC(C(=O)NCCC(=O)O)=CC=C1\N=N\C1=CC=C(O)C(C(O)=O)=C1 IPOKCKJONYRRHP-FMQUCBEESA-N 0.000 description 1
• 230000006399 behavior Effects 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 230000001588 bifunctional effect Effects 0.000 description 1
• 108091008324 binding proteins Proteins 0.000 description 1
• 230000003115 biocidal effect Effects 0.000 description 1
• 230000008236 biological pathway Effects 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 230000036983 biotransformation Effects 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 230000008993 bowel inflammation Effects 0.000 description 1
• 229960004436 budesonide Drugs 0.000 description 1
• 238000010804 cDNA synthesis Methods 0.000 description 1
• 238000012219 cassette mutagenesis Methods 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 230000021164 cell adhesion Effects 0.000 description 1
• 230000030570 cellular localization Effects 0.000 description 1
• 238000012412 chemical coupling Methods 0.000 description 1
• 239000007795 chemical reaction product Substances 0.000 description 1
• 210000003483 chromatin Anatomy 0.000 description 1
• 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
• 229960003405 ciprofloxacin Drugs 0.000 description 1
• 238000007621 cluster analysis Methods 0.000 description 1
• 238000011260 co-administration Methods 0.000 description 1
• 230000008951 colonic inflammation Effects 0.000 description 1
• 208000029742 colonic neoplasm Diseases 0.000 description 1
• 238000002648 combination therapy Methods 0.000 description 1
• 239000003184 complementary RNA Substances 0.000 description 1
• 239000008139 complexing agent Substances 0.000 description 1
• 238000004590 computer program Methods 0.000 description 1
• 230000001268 conjugating effect Effects 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 239000000356 contaminant Substances 0.000 description 1
• 238000011461 current therapy Methods 0.000 description 1
• 238000005520 cutting process Methods 0.000 description 1
• UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 229940127089 cytotoxic agent Drugs 0.000 description 1
• 239000002254 cytotoxic agent Substances 0.000 description 1
• 231100000599 cytotoxic agent Toxicity 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
• SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
• RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
• HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
• NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
• 125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 description 1
• 238000007405 data analysis Methods 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 230000018044 dehydration Effects 0.000 description 1
• 238000006297 dehydration reaction Methods 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 230000030609 dephosphorylation Effects 0.000 description 1
• 238000006209 dephosphorylation reaction Methods 0.000 description 1
• 239000002274 desiccant Substances 0.000 description 1
• 230000001627 detrimental effect Effects 0.000 description 1
• 239000000032 diagnostic agent Substances 0.000 description 1
• 229940039227 diagnostic agent Drugs 0.000 description 1
• 238000000502 dialysis Methods 0.000 description 1
• FOCAHLGSDWHSAH-UHFFFAOYSA-N difluoromethanethione Chemical compound FC(F)=S FOCAHLGSDWHSAH-UHFFFAOYSA-N 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
• LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• 235000021158 dinner Nutrition 0.000 description 1
• 208000007784 diverticulitis Diseases 0.000 description 1
• 230000002222 downregulating effect Effects 0.000 description 1
• 238000002651 drug therapy Methods 0.000 description 1
• 201000006549 dyspepsia Diseases 0.000 description 1
• 230000013020 embryo development Effects 0.000 description 1
• 230000002996 emotional effect Effects 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 208000010227 enterocolitis Diseases 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
• 230000008378 epithelial damage Effects 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• 210000003238 esophagus Anatomy 0.000 description 1
• 108010038795 estrogen receptors Proteins 0.000 description 1
• 235000019441 ethanol Nutrition 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 201000005884 exanthem Diseases 0.000 description 1
• 230000029142 excretion Effects 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 238000013401 experimental design Methods 0.000 description 1
• 210000002744 extracellular matrix Anatomy 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 239000011536 extraction buffer Substances 0.000 description 1
• 230000001815 facial effect Effects 0.000 description 1
• 230000002349 favourable effect Effects 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 230000004761 fibrosis Effects 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
• 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 210000005095 gastrointestinal system Anatomy 0.000 description 1
• 238000003500 gene array Methods 0.000 description 1
• 230000004547 gene signature Effects 0.000 description 1
• 230000030279 gene silencing Effects 0.000 description 1
• 102000054766 genetic haplotypes Human genes 0.000 description 1
• 101150032155 gli1 gene Proteins 0.000 description 1
• 229940116332 glucose oxidase Drugs 0.000 description 1
• 235000019420 glucose oxidase Nutrition 0.000 description 1
• 230000009459 hedgehog signaling Effects 0.000 description 1
• 238000005534 hematocrit Methods 0.000 description 1
• 125000000623 heterocyclic group Chemical group 0.000 description 1
• 239000000833 heterodimer Substances 0.000 description 1
• 238000010562 histological examination Methods 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 102000055466 human ATXN3L Human genes 0.000 description 1
• 102000052265 human Batf2 Human genes 0.000 description 1
• 102000054350 human CHI3L1 Human genes 0.000 description 1
• 102000048466 human DEFA5 Human genes 0.000 description 1
• 102000050514 human DEFA6 Human genes 0.000 description 1
• 102000051854 human FARS2 Human genes 0.000 description 1
• 102000046028 human KCTD8 Human genes 0.000 description 1
• 102000054358 human NR4A1 Human genes 0.000 description 1
• 102000045309 human NT5E Human genes 0.000 description 1
• 102000045286 human REG1B Human genes 0.000 description 1
• 102000051258 human S100A8 Human genes 0.000 description 1
• 102000055250 human S100P Human genes 0.000 description 1
• 102000057429 human SAA1 Human genes 0.000 description 1
• 102000047851 human SPRED2 Human genes 0.000 description 1
• 102000053890 human TIMP1 Human genes 0.000 description 1
• 102000057462 human TYMP Human genes 0.000 description 1
• 102000043617 human WNT16 Human genes 0.000 description 1
• 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 238000012872 hydroxylapatite chromatography Methods 0.000 description 1
• 230000006607 hypermethylation Effects 0.000 description 1
• 208000009326 ileitis Diseases 0.000 description 1
• 201000008254 ileocolitis Diseases 0.000 description 1
• 238000002991 immunohistochemical analysis Methods 0.000 description 1
• 238000012308 immunohistochemistry method Methods 0.000 description 1
• 238000002650 immunosuppressive therapy Methods 0.000 description 1
• 238000012405 in silico analysis Methods 0.000 description 1
• 238000000126 in silico method Methods 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 208000027138 indeterminate colitis Diseases 0.000 description 1
• 230000008595 infiltration Effects 0.000 description 1
• 238000001764 infiltration Methods 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 238000013101 initial test Methods 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 230000015788 innate immune response Effects 0.000 description 1
• 229960003786 inosine Drugs 0.000 description 1
• 206010022437 insomnia Diseases 0.000 description 1
• 238000007689 inspection Methods 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 238000001361 intraarterial administration Methods 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 238000010253 intravenous injection Methods 0.000 description 1
• 238000002642 intravenous therapy Methods 0.000 description 1
• 230000009545 invasion Effects 0.000 description 1
• 238000011835 investigation Methods 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 201000008242 jejunoileitis Diseases 0.000 description 1
• 210000001630 jejunum Anatomy 0.000 description 1
• 208000018934 joint symptom Diseases 0.000 description 1
• 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 229940057428 lactoperoxidase Drugs 0.000 description 1
• 108010091798 leucylleucine Proteins 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 230000004807 localization Effects 0.000 description 1
• 230000033001 locomotion Effects 0.000 description 1
• 238000003670 luciferase enzyme activity assay Methods 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 238000009115 maintenance therapy Methods 0.000 description 1
• 230000036210 malignancy Effects 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 238000001819 mass spectrum Methods 0.000 description 1
• 229960003151 mercaptamine Drugs 0.000 description 1
• KBOPZPXVLCULAV-UHFFFAOYSA-M mesalaminate(1-) Chemical compound NC1=CC=C(O)C(C([O-])=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-M 0.000 description 1
• 238000010197 meta-analysis Methods 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• 229960004584 methylprednisolone Drugs 0.000 description 1
• VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
• 229960000282 metronidazole Drugs 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 108010029942 microperoxidase Proteins 0.000 description 1
• 238000000386 microscopy Methods 0.000 description 1
• 239000004005 microsphere Substances 0.000 description 1
• 210000004688 microtubule Anatomy 0.000 description 1
• 235000013336 milk Nutrition 0.000 description 1
• 239000008267 milk Substances 0.000 description 1
• 210000004080 milk Anatomy 0.000 description 1
• 238000007479 molecular analysis Methods 0.000 description 1
• 230000009149 molecular binding Effects 0.000 description 1
• 239000003068 molecular probe Substances 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 239000000178 monomer Substances 0.000 description 1
• 210000004400 mucous membrane Anatomy 0.000 description 1
• 230000036457 multidrug resistance Effects 0.000 description 1
• 210000000066 myeloid cell Anatomy 0.000 description 1
• UPSFMJHZUCSEHU-JYGUBCOQSA-N n-[(2s,3r,4r,5s,6r)-2-[(2r,3s,4r,5r,6s)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-(4-methyl-2-oxochromen-7-yl)oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](NC(C)=O)[C@H](OC=2C=C3OC(=O)C=C(C)C3=CC=2)O[C@@H]1CO UPSFMJHZUCSEHU-JYGUBCOQSA-N 0.000 description 1
• 230000009826 neoplastic cell growth Effects 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 239000002751 oligonucleotide probe Substances 0.000 description 1
• 238000002515 oligonucleotide synthesis Methods 0.000 description 1
• 229920001542 oligosaccharide Polymers 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• 230000001590 oxidative effect Effects 0.000 description 1
• 238000002638 palliative care Methods 0.000 description 1
• 229940055729 papain Drugs 0.000 description 1
• 235000019834 papain Nutrition 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 238000005192 partition Methods 0.000 description 1
• 230000009054 pathological process Effects 0.000 description 1
• 229940111202 pepsin Drugs 0.000 description 1
• 238000010647 peptide synthesis reaction Methods 0.000 description 1
• 239000008194 pharmaceutical composition Substances 0.000 description 1
• 230000035479 physiological effects, processes and functions Effects 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
• 108010054442 polyalanine Proteins 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 230000003234 polygenic effect Effects 0.000 description 1
• 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 238000011176 pooling Methods 0.000 description 1
• 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 1
• 230000004481 post-translational protein modification Effects 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 108020001213 potassium channel Proteins 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 238000002203 pretreatment Methods 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 230000003449 preventive effect Effects 0.000 description 1
• 230000037452 priming Effects 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 230000001915 proofreading effect Effects 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 239000012474 protein marker Substances 0.000 description 1
• 230000012743 protein tagging Effects 0.000 description 1
• 230000002797 proteolythic effect Effects 0.000 description 1
• XKMLYUALXHKNFT-UHFFFAOYSA-N rGTP Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O XKMLYUALXHKNFT-UHFFFAOYSA-N 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 229910052761 rare earth metal Inorganic materials 0.000 description 1
• 150000002910 rare earth metals Chemical class 0.000 description 1
• 206010037844 rash Diseases 0.000 description 1
• 102000005962 receptors Human genes 0.000 description 1
• 108020003175 receptors Proteins 0.000 description 1
• 238000003259 recombinant expression Methods 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 238000007670 refining Methods 0.000 description 1
• 230000004043 responsiveness Effects 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 238000012340 reverse transcriptase PCR Methods 0.000 description 1
• PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 108091092562 ribozyme Proteins 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 238000013391 scatchard analysis Methods 0.000 description 1
• 238000003345 scintillation counting Methods 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 238000004062 sedimentation Methods 0.000 description 1
• 238000012154 short term therapy Methods 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 229910052709 silver Inorganic materials 0.000 description 1
• 239000004332 silver Substances 0.000 description 1
• 231100000046 skin rash Toxicity 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 230000000391 smoking effect Effects 0.000 description 1
• PTLRDCMBXHILCL-UHFFFAOYSA-M sodium arsenite Chemical compound [Na+].[O-][As]=O PTLRDCMBXHILCL-UHFFFAOYSA-M 0.000 description 1
• FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
• 239000012064 sodium phosphate buffer Substances 0.000 description 1
• 229940048086 sodium pyrophosphate Drugs 0.000 description 1
• 238000000638 solvent extraction Methods 0.000 description 1
• 231100000527 sperm abnormality Toxicity 0.000 description 1
• 238000009987 spinning Methods 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 239000007858 starting material Substances 0.000 description 1
• 238000007619 statistical method Methods 0.000 description 1
• 150000003431 steroids Chemical class 0.000 description 1
• 230000004936 stimulating effect Effects 0.000 description 1
• 230000035882 stress Effects 0.000 description 1
• 229940014800 succinic anhydride Drugs 0.000 description 1
• 229960002317 succinimide Drugs 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 210000004876 tela submucosa Anatomy 0.000 description 1
• 230000002123 temporal effect Effects 0.000 description 1
• 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
• 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
• MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
• 125000003396 thiol group Chemical group [H]S* 0.000 description 1
• 229960002175 thyroglobulin Drugs 0.000 description 1
• 230000007838 tissue remodeling Effects 0.000 description 1
• 230000035897 transcription Effects 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• 230000014616 translation Effects 0.000 description 1
• 230000008733 trauma Effects 0.000 description 1
• 238000011269 treatment regimen Methods 0.000 description 1
• 239000001226 triphosphate Substances 0.000 description 1
• 235000011178 triphosphate Nutrition 0.000 description 1
• HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
• 229940038773 trisodium citrate Drugs 0.000 description 1
• 239000012588 trypsin Substances 0.000 description 1
• 239000002753 trypsin inhibitor Substances 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 231100000397 ulcer Toxicity 0.000 description 1
• 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
• 238000011870 unpaired t-test Methods 0.000 description 1
• 238000012795 verification Methods 0.000 description 1
• 230000003442 weekly effect Effects 0.000 description 1
• 230000036642 wellbeing Effects 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• 230000022814 xenobiotic metabolic process Effects 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1